- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Familial heterozygous hypercholesterolaemia; Non-familial hypercholesterolaemia; Familial homozygous hypercholesterolaemia
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 788KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 39KB)
Evolocumab – March 2021
Evolocumab: Injection 420 mg in 3.5 mL single use pre-filled cartridge; Repatha®
Last updated
2 July 2021